Allurion Technologies logo

Allurion TechnologiesNYSE: ALUR

Profile

Sector:

Healthcare

Country:

United States

IPO:

29 March 2021

Next earnings report:

21 March 2025

Last dividends:

N/A

Next dividends:

N/A
$28.03 M
-91%vs. 3y high
28%vs. sector
-vs. 3y high
-vs. sector
-26%vs. 3y high
12%vs. sector
-85%vs. 3y high
20%vs. sector

Price

regular market | 10 min ago
$0.43-$0.13(-23.67%)

Dividend

No data over the past 3 years
$5.37 M$5.57 M
$5.37 M-$9.00 M

Analysts recommendations

Institutional Ownership

ALUR Latest News

Allurion Technologies Inc. (ALUR) Q3 2024 Earnings Call Transcript
seekingalpha.com13 November 2024 Sentiment: NEUTRAL

Allurion Technologies Inc. (NYSE:ALUR ) Q3 2024 Earnings Conference Call November 13, 2024 8:30 AM ET Company Participants Mike Cavanaugh – Investor Relations Shantanu Gaur – Founder and Chief Executive Officer Brian Conyer – Vice President-Digital Health Adrian Wild – Senior Vice President-International Commercial Chris Geberth – Chief Financial Officer Conference Call Participants Josh Jennings – TD Cowen Matt Taylor – Jefferies Operator Thank you for standing by. My name is John, and I'll be your conference operator today.

ALUR Stock Declines Despite Submitting PMA for Allurion Balloon
zacks.com24 October 2024 Sentiment: NEUTRAL

Allurion submits the first three modules of PMA application to the FDA for the Allurion Balloon.

October's 4 Best Penny Stocks: High-Risk, High-Reward Picks
marketbeat.com04 October 2024 Sentiment: NEUTRAL

Most investors' definition of a penny stock has broadened to include not just companies trading at less than $1 per share, but also those with slightly higher stock prices up to about $5 per share. Regardless of your exact threshold, these firms remain a high-risk, high-reward proposition.

Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024
businesswire.com16 July 2024 Sentiment: POSITIVE

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that it will report financial results for the second quarter 2024 on Tuesday, August 13, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:30 AM ET. To access the conference call by telephone, please dial (888) 330-3417 (domestic) or +1 646 960 0804 (intern.

Allurion Announces Launch of Offering of Common Stock and Warrants
businesswire.com26 June 2024 Sentiment: POSITIVE

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that it has launched an underwritten public offering of up to $20 million of its common stock, par value $0.0001 per share (the “Shares”), and warrants to purchase Shares (the “Warrants” and, together with the Shares, the “Securities”). Jefferies and TD Cowen are acting as joint book-running managers and representatives of the underwriter.

Allurion (ALUR) Unveils Positive Data for Its Balloon Therapy
zacks.com14 June 2024 Sentiment: POSITIVE

Allurion (ALUR) announces positive weight loss data for its gastric balloon technology.

Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
zacks.com11 June 2024 Sentiment: POSITIVE

The heavy selling pressure might have exhausted for Allurion Technologies, Inc. (ALUR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer
businesswire.com05 June 2024 Sentiment: POSITIVE

NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced the appointment of Ojas A. Buch as its new Chief Operating Officer. Effective June 3, 2024, Ojas assumed the role of Chief Operating Officer and will lead the company's Research and Development, Manufacturing and Operations, Quality and Regulatory, and Business Development and Innovation functions. He will also play a crucial role in commercial functions while working.

Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s
businesswire.com30 May 2024 Sentiment: POSITIVE

NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the expansion of its Artificial Intelligence (AI)-powered weight loss coach, Coach Iris, to support patients prescribed GLP-1s and other anti-obesity medications and the first commercial agreements for its Virtual Care Suite (VCS) in the United States. With this update to Coach Iris, patients now have access to 24/7 personalized coaching and guidance specific to GLP-1.

Why Is Allurion (ALUR) Stock Up 65% Today?
InvestorPlace04 April 2024 Sentiment: POSITIVE

Little-known medical device firm Allurion (NYSE: ALUR ) — which is focused on ending obesity via its swallowable and “procedure-less” intragastric balloon — saw its shares skyrocket on Thursday. Earlier this morning, management announced the commercial availability of its comprehensive Virtual Care Suite (VCS) in the U.S. ALUR stock likely benefited from rising interest in anti-obesity treatments.

What type of business is Allurion Technologies?

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

What sector is Allurion Technologies in?

Allurion Technologies is in the Healthcare sector

What industry is Allurion Technologies in?

Allurion Technologies is in the Medical Devices industry

What country is Allurion Technologies from?

Allurion Technologies is headquartered in United States

When did Allurion Technologies go public?

Allurion Technologies initial public offering (IPO) was on 29 March 2021

What is Allurion Technologies website?

https://www.allurion.com

Is Allurion Technologies in the S&P 500?

No, Allurion Technologies is not included in the S&P 500 index

Is Allurion Technologies in the NASDAQ 100?

No, Allurion Technologies is not included in the NASDAQ 100 index

Is Allurion Technologies in the Dow Jones?

No, Allurion Technologies is not included in the Dow Jones index

When was Allurion Technologies the previous earnings report?

No data

When does Allurion Technologies earnings report?

The next expected earnings date for Allurion Technologies is 21 March 2025